GLYCOVAXYN
GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.
GLYCOVAXYN
Social Links:
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
2004-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.glycovaxyn.com
Total Employee:
11+
Status:
Active
Contact:
+41447338585
Total Funding:
34.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Namecheap DNS Contabo
Similar Organizations
AM Technology
AM Technology designs and manufactures dynamically mixed continuous flow reactors.
Current Employees Featured
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - GlycoVaxyn
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity investment in Series B - GlycoVaxyn
Index Ventures
Index Ventures investment in Series B - GlycoVaxyn
Sofinnova Partners
Sofinnova Partners investment in Series A - GlycoVaxyn
Index Ventures
Index Ventures investment in Series A - GlycoVaxyn
Sofinnova Partners
Sofinnova Partners investment in Seed Round - GlycoVaxyn
Index Ventures
Index Ventures investment in Seed Round - GlycoVaxyn
Official Site Inspections
http://www.glycovaxyn.com
- Host name: k8s-svc-lander-namecheap-expired-01.us-ord.parklogic.net
- IP address: 172.239.57.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
